Rankings
▼
Calendar
BHVN Q4 2020 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena
BHVN
Biohaven Ltd.
$1B
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$35M
Gross Profit
$25M
71.6% margin
Operating Income
-$171M
-486.1% margin
Net Income
-$218M
-620.1% margin
EPS (Diluted)
$-4.49
QoQ Revenue Growth
+98.8%
Cash Flow
Operating Cash Flow
-$505M
Free Cash Flow
-$506M
Stock-Based Comp.
$33M
Balance Sheet
Total Assets
$111M
Total Liabilities
$35M
Stockholders' Equity
$17M
Cash & Equivalents
$83M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$35M
$0
—
Gross Profit
$25M
$0
—
Operating Income
-$171M
-$135M
-26.5%
Net Income
-$218M
-$149M
-45.9%
← FY 2020
All Quarters
Q1 2021 →